SB206 12%

DRUG3 trials

Sponsors

Novan, Inc.

Conditions

Molluscum Contagiosum

Phase 2

A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum

CompletedNCT03436615

Novan, Inc.Molluscum Contagiosum

Start: 2018-01-24End: 2018-11-03Updated: 2023-05-06

Phase 3

A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MC

CompletedNCT03927703

Novan, Inc.Molluscum Contagiosum

Start: 2019-06-13End: 2020-02-03Updated: 2023-03-23

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

CompletedNCT03927716

Novan, Inc.Molluscum Contagiosum

Start: 2019-06-03End: 2020-01-29Updated: 2022-12-27

Related Papers

SB206, a Nitric Oxide–Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance

JID Innovations2021-05-0520 citations